The grocery store aisles are packed with products promising better health, cleaner eating, and natural goodness. Marketing ...

Victor Conte was at the heart of the biggest sports scandal in U.S. history in the early 2000s, which ensnared MLB stars, NFL players and Olympic champions ...

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.

Excessive salt consumption poses serious health risks, including high blood pressure, heart disease, stroke, and kidney ...

Intensity Therapeutics ( INTS ), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase 1/2 results on its candidate for metastatic or refractory cancers, INT230-6.

Intensity Therapeutics Inc. company and executive profile by Barron's. View the latest INTS company infomation and executive bios.

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Amphista Therapeutics Ltd. has divulged proteolysis targeting chimera (PROTAC) compounds comprising an F-Box only protein 22 (FBXO22)-binding moiety coupled to a transcriptional enhancer factor TEF ...

MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...

Lainie Jones believed in the power of being early. She credited early detection as the reason she survived six different types of cancer—and it became the driving force behind her lifelong advocacy ...

LONDON, Oct 15 (Reuters) - German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round to date, contributing to a total of 495 million ...